pyridoxamine dihydrochloride has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broome, BR; Dwyer, JP; Fox, JW; Greco, BA; Greene, LE; Lewis, JB; Packham, D; Peterson, R; Sika, M; Umanath, K | 1 |
| Atkins, RC; Berl, T; Blumenthal, S; Greene, T; Herskovits, T; Hunsicker, LG; Lewis, EJ; Lewis, JB; Packham, DK; Pohl, MA; Raz, I; Reutens, AT; Rohde, RD; Spitalewiz, S; Yagil, Y; Yerushalmy, Y | 1 |
2 trial(s) available for pyridoxamine dihydrochloride and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Pyridoxamine dihydrochloride in diabetic nephropathy (PIONEER-CSG-17): lessons learned from a pilot study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Antioxidants; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Pilot Projects; Pyridoxamine | 2015 |
Pyridorin in type 2 diabetic nephropathy.
Topics: Aged; Creatinine; Cystatin C; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Proteinuria; Pyridoxal Phosphate; Pyridoxamine | 2012 |